Email Updates

You are here

Home

AVAC's Blog: P-Values

  • Conducting Research With a Heart: The stories of CROI 2016 Award Recipients

    Morenike Ukpong, Associate Professor at Obafemi Awolowo University and Coordinator of the New HIV Vaccine and Microbicide Advocacy Society in Ife, Nigeria, writes why she believes CROI 2016 made strides in taking community concerns into consideration. This blog is one in a series written by community scholars who attended CROI 2016.

    February 25, 2016
    HIV Vaccine, Treatment
    Morenike Ukpong

  • AVAC's take on ring trial results—breaking news in HIV prevention

    Results from two trials of HIV prevention for women were released at the 2016 Conference on Retroviruses and Opportunistic Infections. Two trials of a vaginal ring containing the antiretroviral drug dapivirine announced their results. Both ASPIRE and The Ring Study found evidence of modest protection.

    February 22, 2016
    Microbicides
    AVAC

  • New Px Wire: What to Watch in 2016

    There are few, if any, quiet years in HIV prevention research and implementation. 2016 promises to be another year of big deal data, whether it's findings from clinical trials, funding levels or readouts from PEPFAR's first year of a geographically focused program plan. We write about this and a lot more to watch for in our new issue of Px Wire.

    February 18, 2016
    HIV Vaccine, Combination Prevention, Hormonal Contraceptives and HIV, Microbicides, PrEP, Treatment, Voluntary Medical Male Circumcision
    AVAC

  • GPP Online Course: Now Accepting Applications

    AVAC is pleased to announce its third global offering of the GPP Online Training Course, a mixed-method web-based approach to building and sustaining capacity around stakeholder engagement! Click the link above for full details on the course, past participants’ experiences and how to apply.

    February 16, 2016
    General
    AVAC

  • Announcing the 2016 AVAC Advocacy Fellows

    AVAC is delighted to announce the 2016 AVAC Advocacy Fellows—the seventh class of Fellows! Please join us in congratulating these six talented advocates. With this new class, the AVAC Fellows family has grown to 50! We hope you’ll find ways to collaborate with the new Fellows in 2016 and beyond.

    February 12, 2016
    General
    AVAC

  • UNAIDS Profiles Six PrEP Pioneers, Uncovering Strategies, Concerns, Motivations and More

    Succinct yet informative interviews with six leading PrEP advocates highlight the many steps of the process from research to rollout where they are gaining ground. The international group featured in this UNAIDS Community Advocacy Update discusses the history of PrEP advocacy and next steps in translating WHO’s 2015 recommendation of daily oral tenofovir-based PrEP as an option for those at substantial risk of HIV acquisition.

    February 10, 2016
    PrEP
    AVAC

  • Letter to President Obama: Don’t stall HIV/AIDS research funding

    Organizations from across the US penned a letter to President Obama urging that the NIH budget include the US $100 million increase for HIV/AIDS research for FY2016 promised by the President in March of 2015. Noting that now is a time to prioritize, not cut HIV/AIDS research, the letter highlights the potential for research advances to help “end the scourge of HIV/AIDS”, a priority the President himself called out in his recent State of the Union speech.

    January 21, 2016
    General

  • Sweet 16: HIV Advocates to Watch in 2016

    AVAC joins My Fabulous Disease Blogger, Mark King, in his recognition and praise for the promise of 16 diverse HIV leaders. His list includes Cassie Warren and Nick Feustal who—in addition to being leaders in the great work described in Mark’s piece—are also members of AVAC’s PxROAR program.

    January 6, 2016
    General

  • Develop, Demonstrate, Deliver: Model shows AIDS vaccine is essential to conclusively end epidemic

    With recent advances in ARV-based HIV prevention implementation, some may ask whether the world still needs an AIDS vaccine to end the epidemic? A new modeling analysis, published this month in the open-access journal PLoS ONE, answers this question with a resounding yes.

    January 6, 2016
    HIV Vaccine
    AVAC

  • When PrEP Educators Don't Like PrEP: Minister Rob Newells' message to naysayers

    What do you do when the people responsible for PrEP education don’t readily trust the medical system and believe they’re required to push PrEP at the expense of other interventions? Rob Newells weighs in on the need to expand PrEP rollout, countering PrEP detractors during and gives personal reflections on what might have been if PrEP were available a decade ago.

    January 5, 2016
    PrEP
    Rob Newells

Pages

view more